Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Stoppa-Lyonnet

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Journal of Medical Genetics|November 1, 2005
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndromeG Bougeard, S Baert-Desurmont, I Tournier, et al.
Journal of Medical Genetics|August 3, 2000
A survey of the current clinical facilities for the management of familial cancer in Europe. European Union BIOMED II Demonstration Project: Familial Breast Cancer: audit of a new development in medical practice in European centresS V Hodgson, N E Haites, M Caligo, et al.
Cancer Research|July 15, 1996
Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancersH Sobol, D Stoppa-Lyonnet, B Bressac-de-Paillerets, et al.
International Journal of Cancer|June 19, 2001
Cancer risk in heterozygotes for ataxia-telangiectasiaB Geoffroy-Perez, N Janin, K Ossian, et al.
Pathologie-Biologie|February 2, 2010
[Genetic testing in the context of the revision of the French law on bioethics]D Bonneau, S Marlin, D Sanlaville, et al.
Human Mutation|January 15, 2004
Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSFC Houdayer, M Gauthier-Villars, A Laugé, et al.
Journal of Medical Genetics|May 24, 2001
Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndromeG Bougeard, J M Limacher, C Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Familial invasive breast cancers: worse outcome related to BRCA1 mutationsD Stoppa-Lyonnet, Y Ansquer, H Dreyfus, et al.
Disease Markers|December 14, 1999
Utilisation of prophylactic mastectomy in 10 European centresD G Evans, E Anderson, F Lalloo, et al.
American Journal of Human Genetics|May 1, 1997
BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer GroupD Stoppa-Lyonnet, P Laurent-Puig, L Essioux, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Journal of Medical Genetics|November 1, 2005
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndromeG Bougeard, S Baert-Desurmont, I Tournier, et al.
Journal of Medical Genetics|August 3, 2000
A survey of the current clinical facilities for the management of familial cancer in Europe. European Union BIOMED II Demonstration Project: Familial Breast Cancer: audit of a new development in medical practice in European centresS V Hodgson, N E Haites, M Caligo, et al.
Cancer Research|July 15, 1996
Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancersH Sobol, D Stoppa-Lyonnet, B Bressac-de-Paillerets, et al.
International Journal of Cancer|June 19, 2001
Cancer risk in heterozygotes for ataxia-telangiectasiaB Geoffroy-Perez, N Janin, K Ossian, et al.
Pathologie-Biologie|February 2, 2010
[Genetic testing in the context of the revision of the French law on bioethics]D Bonneau, S Marlin, D Sanlaville, et al.
Human Mutation|January 15, 2004
Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSFC Houdayer, M Gauthier-Villars, A Laugé, et al.
Journal of Medical Genetics|May 24, 2001
Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndromeG Bougeard, J M Limacher, C Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Familial invasive breast cancers: worse outcome related to BRCA1 mutationsD Stoppa-Lyonnet, Y Ansquer, H Dreyfus, et al.
Disease Markers|December 14, 1999
Utilisation of prophylactic mastectomy in 10 European centresD G Evans, E Anderson, F Lalloo, et al.
American Journal of Human Genetics|May 1, 1997
BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer GroupD Stoppa-Lyonnet, P Laurent-Puig, L Essioux, et al.
Pageof 13